No takes yet. Share an insight, caveat, or question.
Statins and renin-angiotensin system blockers share pleiotropic properties that may offer synergistic vascular protection against atherogenic mechanisms.
Faggiotto et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: